New study combines skin scans and DNA to catch melanoma earlier

NCT ID NCT07277920

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at 200 people with suspicious moles that are already scheduled for removal. Researchers will use a special microscope (reflectance confocal microscopy) to take detailed images of the moles and then compare those images with genetic tests from the removed tissue. The goal is to find patterns that help tell harmless moles from early melanomas, which could lead to faster and more accurate diagnosis.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could lead to better, non-invasive tools for spotting early melanoma and reduce unnecessary biopsies.

What could go wrong

This is an observational study, not a treatment trial. It may not directly change patient care, and results might not apply to all skin types or settings.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MELANOMA (SKIN CANCER) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

melanocytic nevus melanoma neutrophil actin dysfunction Nevus, Pigmented

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Dermatology Department, University Hospital of Modena

    RECRUITING

    Modena, Mo, 41125, Italy

    Contact Phone: •••-•••-•••• Email: •••••@•••••